George Horvath

Publications

• Medical Device Dangers: Choosing Ignorance in the Courts and at the FDA
  67 WM. & MARY L. REV. 669 (2026) · William & Mary Law Review · 2026
• Incremental Innovation
  28 SMU SCI. & TECH. L. REV. 131 (2025) · SMU Science and Technology Law Review · 2025
• Empirically Assessing Medical Device Innovation
  25 MINN. J. L. SCI. & TECH. 73 (2024) · Minnesota Journal of Law, Science & Technology · 2024
• Evolution or Revolution in Telehealth Regulation
  9 TEX. A & M L. REV. 12 (2021) · Texas A&M Law Review · 2021
• Off-Label Drug Risks: Toward a New FDA Regulatory Approach
  29 ANNALS HEALTH L. & LIFE SCIS. 101 (2020) · Annals of Health Law and Life Sciences · 2020
• Federal District Court Decisions on the Admissibility of Expert Witness Testimony: An Empirical Study and a Revision of the Conventional Narrative in the Toxic Tort Context
  88 U. CIN. L. REV. 515 (2020) · University of Cincinnati Law Review · 2020

• Emergent Regulatory Systems and Their Challenges: The Case of Combination Medical Products
  94 WASH. L. REV. 1697 (2019) · Washington Law Review · 2019
• Trading Safety for Innovation and Access: An Empirical Evaluation of the FDA’s Premarket Approval Process
  2017 BYU L. REV. 991 (2017) · BYU Law Review · 2017
• Recovery and Preemption: The Collision of the Medicare Secondary Payer Act and the Medical Device Amendments
  103 CAL. L. REV. 1353 (2015) · California Law Review · 2015